Published in Neurol Sci on July 15, 2012
Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res (2013) 1.08
Visual bone marrow mesenchymal stem cell transplantation in the repair of spinal cord injury. Neural Regen Res (2015) 0.78
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications. Stem Cells Int (2015) 0.77
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Generation of mouse induced pluripotent stem cells without viral vectors. Science (2008) 15.25
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature (2008) 7.07
Induction of human neuronal cells by defined transcription factors. Nature (2011) 6.84
Oct4-induced pluripotency in adult neural stem cells. Cell (2009) 6.50
Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell (2011) 6.11
A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell (2008) 5.90
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell (2011) 4.65
Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell (2011) 4.02
Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell (2010) 3.82
Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA (2008) 3.03
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A (2009) 2.80
Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A (2010) 2.52
Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells (2009) 2.51
Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus (2008) 2.37
Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res (2008) 2.29
Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A (2011) 2.09
Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J (2004) 1.93
Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One (2010) 1.66
Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol (2009) 1.65
Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies. J Neurotrauma (2010) 1.54
The timing of surgical intervention in the treatment of spinal cord injury: a systematic review of recent clinical evidence. Spine (Phila Pa 1976) (2006) 1.47
Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol (2001) 1.40
Stem cell therapies for spinal cord injury. Nat Rev Neurol (2010) 1.35
Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells (2010) 1.21
Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells (2010) 1.17
Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev (2011) 1.17
Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward? Pharmacol Ther (2011) 1.07
Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition. Stem Cell Rev (2011) 0.98
Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury? J Cell Physiol (2010) 0.91
Promising new sources for pluripotent stem cells. Stem Cell Rev (2010) 0.91
Schwann cell-like remyelination following transplantation of human umbilical cord blood (hUCB)-derived mesenchymal stem cells in dogs with acute spinal cord injury. J Neurol Sci (2010) 0.90
Will stem cell therapies be safe and effective for treating spinal cord injuries? Br Med Bull (2011) 0.83
Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord. Stem Cell Rev (2010) 0.82
Flaw in induced-stem-cell model. Nature (2011) 0.81
Clinical application of adult olfactory bulb ensheathing glia for nervous system repair. Exp Neurol (2010) 0.79
Olfactory ensheathing cells can reduce the tissue loss but not the cavity formation in contused spinal cord of rats. J Neurol Sci (2011) 0.77
The efficacy of antioxidants in functional recovery of spinal cord injured rats: an experimental study. Neurol Sci (2011) 0.77
Genetic enhancement of learning and memory in mice. Nature (1999) 8.06
Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science (1999) 5.98
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol (2001) 4.38
Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron (2001) 3.91
Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc Natl Acad Sci U S A (1999) 3.90
PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell (1998) 3.79
Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci U S A (2000) 3.46
Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell (2001) 3.44
Deformation and flow of membrane into tethers extracted from neuronal growth cones. Biophys J (1996) 3.42
Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proc Natl Acad Sci U S A (2000) 3.41
Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem (1999) 3.35
Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet (2001) 3.27
A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc Natl Acad Sci U S A (2000) 3.08
Modulation of membrane dynamics and cell motility by membrane tension. Trends Cell Biol (1996) 2.94
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc Natl Acad Sci U S A (1998) 2.81
Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1994) 2.81
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49
The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci (2000) 2.42
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol (2002) 2.34
Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill (2013) 2.34
A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Pharmacogenomics J (2010) 2.30
alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci U S A (1998) 2.28
Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood (1999) 2.26
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology (1999) 2.16
The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology (1997) 2.14
Modulation of folding pathways of exported proteins by the leader sequence. Science (1988) 2.10
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem (2000) 1.99
Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem (2001) 1.97
Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis (2001) 1.96
The cytoplasmic domain of FtsK protein is required for resolution of chromosome dimers. Mol Microbiol (1999) 1.95
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology (2004) 1.92
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol (1999) 1.87
Harvesting the genome's bounty: integrative genomics. Cold Spring Harb Symp Quant Biol (2003) 1.84
Visual attention to the periphery is enhanced in congenitally deaf individuals. J Neurosci (2000) 1.83
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83
A humoral stress response in Drosophila. Curr Biol (2001) 1.82
Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82
Glycerol production by microbial fermentation: a review. Biotechnol Adv (2001) 1.69
Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J (2010) 1.69
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia (2008) 1.67
The nucleotide sequence of the cyd locus encoding the two subunits of the cytochrome d terminal oxidase complex of Escherichia coli. J Biol Chem (1988) 1.66
Impact of early deafness and early exposure to sign language on the cerebral organization for motion processing. J Neurosci (2001) 1.66
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group. Circulation (2000) 1.65
Mutants in three novel complementation groups inhibit membrane protein insertion into and soluble protein translocation across the endoplasmic reticulum membrane of Saccharomyces cerevisiae. J Cell Biol (1992) 1.60
Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol (1997) 1.59
Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood (2000) 1.58
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res (2000) 1.57
Risk and predictors for pregnancy-related complications in women with heart disease. Circulation (1997) 1.56
Linkage of structure at the proximal femur to chromosomes 3, 7, 8, and 19. J Bone Miner Res (2003) 1.55
Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis. Ann Oncol (2012) 1.53
Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000. Acta Paediatr (2002) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
A role for Dictyostelium racE in cortical tension and cleavage furrow progression. J Cell Biol (1998) 1.49
An unidentified species of Theileria infective for cattle discovered in China. Trop Anim Health Prod (1997) 1.47
k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction. Pharmacogenomics J (2010) 1.46
A developmental switch in neurotransmitter flux enhances synaptic efficacy by affecting AMPA receptor activation. Neuron (2001) 1.44
Net primary productivity of China's terrestrial ecosystems from a process model driven by remote sensing. J Environ Manage (2007) 1.43
Complete heart block and sudden death in mice overexpressing calreticulin. J Clin Invest (2001) 1.43
Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J (1998) 1.43
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest (2001) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
FK506 in the treatment of children with nephrotic syndrome of different pathological types. Clin Nephrol (2006) 1.42
Characterisation and validation of a novel panel of the six short tandem repeats for genetic counselling in Chinese haemophilia A pedigrees. Haemophilia (2012) 1.42
Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene (2009) 1.40
Experimental study on nonuniformity of line jitter in CCD images. Appl Opt (2001) 1.39
Effect of 24-h blood pressure levels and circadian blood pressure rhythm on left ventricular structure and function in isolated systolic hypertension. Int J Cardiol (1994) 1.39
Identification of the cydC locus required for expression of the functional form of the cytochrome d terminal oxidase complex in Escherichia coli. J Bacteriol (1987) 1.38
Effect of perfusion pressure on the splanchnic circulation after CPB: a pilot study. Minerva Anestesiol (2014) 1.37
Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol (1997) 1.35
Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr (2000) 1.34
Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res (1994) 1.33
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models. J Med Chem (2001) 1.32
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect (2009) 1.31
Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J Immunol (2001) 1.31
Identification of a new form of electron coupling in the Bi2Sr2CaCu2O8 superconductor by laser-based angle-resolved photoemission spectroscopy. Phys Rev Lett (2008) 1.31
Mutation of phosphoserine 389 affects p53 function in vivo. J Biol Chem (1996) 1.31
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem (2001) 1.28
Transmembrane redox sensor of ryanodine receptor complex. J Biol Chem (2000) 1.28
Better discrimination of hip fracture using bone density, geometry and architecture. Osteoporos Int (1995) 1.27
p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J (2001) 1.26
Integrin-cytoskeletal interactions in neuronal growth cones. J Neurosci (1995) 1.25
Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int (2007) 1.25
Global patterns of gene expression in rice cultivars undergoing a susceptible or resistant interaction with the parasitic plant Striga hermonthica. New Phytol (2008) 1.24
MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr (2001) 1.24
A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci U S A (2000) 1.23
Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J Cell Biochem (2000) 1.22
Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science (1994) 1.22
IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene (2011) 1.21
Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience (2007) 1.21
Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst (2001) 1.21
Bundling of actin filaments by elongation factor 1 alpha inhibits polymerization at filament ends. J Cell Biol (1996) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21